Prospectively assessing serum neurofilament light chain levels as a biomarker of <scp>paclitaxel‐induced</scp> peripheral neurotoxicity in breast cancer patients-Reference-Cited by-同舟云学术

Prospectively assessing serum neurofilament light chain levels as a biomarker of paclitaxel‐induced peripheral neurotoxicity in breast cancer patients

Published:2022-04-13 Issue:2 Volume:27 Page:166-174
ISSN:1085-9489
Container-title:Journal of the Peripheral Nervous System
language:en
Short-container-title:J Peripheral Nervous Sys

Author:

Karteri Sofia¹,Bruna Jordi²^ORCID,Argyriou Andreas A.³,Mariotto Sara⁴^ORCID,Velasco Roser²,Alemany Montse²,Kalofonou Foteini⁵,Alberti Paola⁶⁷^ORCID,Dinoto Alessandro⁴,Velissaris Dimitrios⁸,Stradella Agostina⁹,Cavaletti Guido⁶⁷^ORCID,Ferrari Sergio⁴^ORCID,Kalofonos Haralabos P.¹^ORCID

Affiliation:

1. Department of Medicine‐Division of Oncology University Hospital of Patras Patras Greece

2. Neuro‐Oncology Unit Hospital Universitari de Bellvitge‐ICO L'Hospitalet (IDIBELL) Barcelona Spain

3. Neurology Department Saint Andrew's General Hospital of Patras Patras Greece

4. Neurology Unit, Department of Neuroscience, Biomedicine and Movement Sciences University of Verona Verona Italy

5. Department of Oncology Imperial NHS Healthcare Trust, Charing Cross Hospital London UK

6. Experimental Neurology Unit, School of Medicine and Surgery University of Milano‐Bicocca Monza Italy

7. NEUROMI (Milan Center for Neuroscience) Milan Italy

8. Department of Internal Medicine University Hospital of Patras Patras Greece

9. Department of Medical Oncology Breast Cancer Unit, ICO L'Hospitalet (IDIBELL) Barcelona Spain

Funder

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Neurology (clinical),General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jns.12493

Reference46 articles.

1. Healthcare Costs and Workloss Burden of Patients with Chemotherapy-Associated Peripheral Neuropathy in Breast, Ovarian, Head and Neck, and Nonsmall Cell Lung Cancer

2. Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy

3. Neuromuscular complications of cancer therapy

4. Taxane and epothilone‐induced peripheral neurotoxicity: from pathogenesis to treatment;Tamburin S;J Peripher Nerv Syst,2019

5. Management of Side Effects in the Personalized Medicine Era: Chemotherapy-Induced Peripheral Neuropathy

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurofilament light chain as a biomarker of chemotherapy-induced peripheral neuropathy;Trends in Pharmacological Sciences;2024-09

2. Blood biomarkers for neuroaxonal injury and astrocytic activation in chemotherapy-induced peripheral neuropathy;Acta Oncologica;2024-08-05

3. Insights into Dysregulated Neurological Biomarkers in Cancer;Cancers;2024-07-27

4. Plasma neurofilament light chain levels in chemotherapy‐induced peripheral neurotoxicity according to type of anticancer drug;European Journal of Neurology;2024-07

5. Evaluation of the Effect of Loratadine versus Diosmin/Hesperidin Combination on Vinca Alkaloids-Induced Neuropathy: A Randomized Controlled Clinical Trial;Pharmaceuticals;2024-05-09